Pius Maliakal
- Pathology and Forensic Medicine top 1%
- Oncology top 5%
- Biochemistry top 0.5%
- Molecular Biology
- Radiology, Nuclear Medicine and Imaging top 5%
- Co-authors
- Xiaofeng MengChung S. YangMao‐Jung LeeSompon WanwimolrukSaileta PrabhuLaishun ChenFlordeliza Y. BondocSandra Möhr
- Topics
- HER2/EGFR in Cancer Research (20 papers)Cancer Treatment and Pharmacology (10 papers)Radiopharmaceutical Chemistry and Applications (8 papers)
- Partner nations
- United StatesNew ZealandGermany
In The Last Decade
Pius Maliakal
45 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Pathology and Forensic Medicine 1.2k
- Oncology 875
- Biochemistry 736
- Molecular Biology 650
- Radiology, Nuclear Medicine and Imaging 350
Countries citing papers authored by Pius Maliakal
This map shows the geographic impact of Pius Maliakal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pius Maliakal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pius Maliakal more than expected).
Fields of papers citing papers by Pius Maliakal
This network shows the impact of papers produced by Pius Maliakal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pius Maliakal. The network helps show where Pius Maliakal may publish in the future.
Co-authorship network of co-authors of Pius Maliakal
This figure shows the co-authorship network connecting the top 25 collaborators of Pius Maliakal. A scholar is included among the top collaborators of Pius Maliakal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pius Maliakal. Pius Maliakal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 6 | |
| 3 | 111 | |
| 4 | 139 | |
| 5 | 15 | |
| 6 | 5 | |
| 7 | 252 | |
| 8 | 4 | |
| 9 | 3 | |
| 10 | 21 | |
| 11 | 34 | |
| 12 | 38 | |
| 13 | 54 | |
| 14 | 7 | |
| 15 | 27 | |
| 16 | 19 | |
| 17 | Pharmacokinetics of Tea Catechins after Ingestion of Green Tea and (−)-Epigallocatechin-3-gallate by Humans | 24 |
| 18 | 9 | |
| 19 | 5 | |
| 20 | 53 |
About Pius Maliakal
Pius Maliakal is a scholar working on Applied Microbiology and Biotechnology, Oncology and Biochemistry, having authored 45 papers that have together received 2.9k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (20 papers), Cancer Treatment and Pharmacology (10 papers) and Radiopharmaceutical Chemistry and Applications (8 papers). The work is most often cited by research in Biochemistry (736 citations), Applied Microbiology and Biotechnology (238 citations) and Pathology and Forensic Medicine (1.2k citations). Pius Maliakal has collaborated with scholars based in United States, New Zealand and Germany. Frequent co-authors include Xiaofeng Meng, Chung S. Yang, Mao‐Jung Lee, Sompon Wanwimolruk, Saileta Prabhu, Laishun Chen, Flordeliza Y. Bondoc, Sandra Möhr, George H. Lambert and Hong Lu. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.